Straumann Holding AG

LSE:0QMV Stock Report

Market Cap: CHF 18.0b

Straumann Holding Valuation

Is 0QMV undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0QMV when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0QMV (CHF112.75) is trading above our estimate of fair value (CHF109.08)

Significantly Below Fair Value: 0QMV is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0QMV?

Key metric: As 0QMV is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0QMV. This is calculated by dividing 0QMV's market cap by their current earnings.
What is 0QMV's PE Ratio?
PE Ratio62.5x
EarningsCHF 287.88m
Market CapCHF 18.00b

Price to Earnings Ratio vs Peers

How does 0QMV's PE Ratio compare to its peers?

The above table shows the PE ratio for 0QMV vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average29.9x
SN. Smith & Nephew
34.8x22.7%UK£8.6b
NIOX NIOX Group
22.8x15.8%UK£250.7m
CTEC ConvaTec Group
36.4x20.3%UK£4.5b
EKF EKF Diagnostics Holdings
25.7xn/aUK£122.7m
0QMV Straumann Holding
62.5x21.2%CHF 18.0b

Price-To-Earnings vs Peers: 0QMV is expensive based on its Price-To-Earnings Ratio (62.5x) compared to the peer average (29.9x).

Price to Earnings Ratio vs Industry

How does 0QMV's PE Ratio compare vs other companies in the European Medical Equipment Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0QMV 62.5xIndustry Avg. 30.7xNo. of Companies8PE01632486480+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0QMV is expensive based on its Price-To-Earnings Ratio (62.5x) compared to the European Medical Equipment industry average (30.9x).

Price to Earnings Ratio vs Fair Ratio

What is 0QMV's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0QMV PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio62.5x
Fair PE Ratio46.2x

Price-To-Earnings vs Fair Ratio: 0QMV is expensive based on its Price-To-Earnings Ratio (62.5x) compared to the estimated Fair Price-To-Earnings Ratio (46.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0QMV forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 112.75
CHF 131.00
+16.2%
16.9%CHF 175.00CHF 90.00n/a18
Dec ’25CHF 114.25
CHF 131.12
+14.8%
17.3%CHF 175.00CHF 90.00n/a17
Nov ’25CHF 116.25
CHF 133.82
+15.1%
16.3%CHF 175.00CHF 90.00n/a17
Oct ’25CHF 139.12
CHF 137.06
-1.5%
16.4%CHF 175.00CHF 90.00n/a18
Sep ’25CHF 125.50
CHF 134.83
+7.4%
16.9%CHF 175.00CHF 90.00n/a18
Aug ’25CHF 113.45
CHF 134.33
+18.4%
18.1%CHF 175.00CHF 90.00n/a18
Jul ’25CHF 112.40
CHF 134.39
+19.6%
18.4%CHF 175.00CHF 90.00n/a18
Jun ’25CHF 117.30
CHF 135.94
+15.9%
18.2%CHF 175.00CHF 90.00n/a18
May ’25CHF 126.97
CHF 138.67
+9.2%
18.4%CHF 175.00CHF 90.00n/a18
Apr ’25CHF 144.02
CHF 142.32
-1.2%
18.4%CHF 175.00CHF 90.00n/a19
Mar ’25CHF 142.75
CHF 134.22
-6.0%
17.7%CHF 168.00CHF 90.00n/a18
Feb ’25CHF 138.96
CHF 128.22
-7.7%
16.1%CHF 153.00CHF 90.00n/a18
Jan ’25CHF 135.60
CHF 125.41
-7.5%
15.2%CHF 150.00CHF 90.00CHF 114.2517
Dec ’24CHF 119.46
CHF 124.47
+4.2%
14.8%CHF 150.00CHF 90.00CHF 114.2517
Nov ’24CHF 105.60
CHF 131.99
+25.0%
16.8%CHF 167.00CHF 90.00CHF 116.2517
Oct ’24CHF 117.20
CHF 135.38
+15.5%
18.0%CHF 167.00CHF 90.00CHF 139.1216
Sep ’24CHF 133.10
CHF 136.82
+2.8%
17.7%CHF 167.00CHF 90.00CHF 125.5017
Aug ’24CHF 143.93
CHF 134.47
-6.6%
20.4%CHF 165.00CHF 82.00CHF 113.4517
Jul ’24CHF 144.16
CHF 133.76
-7.2%
21.1%CHF 165.00CHF 82.00CHF 112.4017
Jun ’24CHF 134.89
CHF 131.88
-2.2%
22.3%CHF 165.00CHF 82.00CHF 117.3016
May ’24CHF 131.63
CHF 124.87
-5.1%
21.4%CHF 160.00CHF 82.00CHF 126.9715
Apr ’24CHF 136.02
CHF 124.53
-8.4%
21.8%CHF 160.00CHF 82.00CHF 144.0215
Mar ’24CHF 123.95
CHF 120.43
-2.8%
21.2%CHF 158.00CHF 80.00CHF 142.7514
Feb ’24CHF 121.05
CHF 116.21
-4.0%
20.4%CHF 150.00CHF 80.00CHF 138.9614
Jan ’24CHF 106.35
CHF 119.00
+11.9%
18.7%CHF 150.00CHF 88.00CHF 135.6013

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 09:04
End of Day Share Price 2025/01/03 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Straumann Holding AG is covered by 47 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hassan Al-WakeelBarclays
Robert BateBarclays
Beatrice FairbairnBerenberg